Early cell loss after angioplasty results in a disproportionate decrease in percutaneous gene transfer to the vessel wall

Human Gene Therapy

Volumn 10, Issue 5, 1999, Pages 711-721

  Rivard, Alain ^a   Luo, Zhengyu ^a   Perlman, Harris ^a,b   Fabre, Jean Etienne ^c   Nguyen, Thao ^a   Maillard, Luc ^a   Walsh, Kenneth ^a,b,d  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; ARTICLE; BLOOD VESSEL WALL; CELL LOSS; CONTROLLED STUDY; GENE TRANSFER; ILIAC ARTERY; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RABBIT; RAT;

ADENOVIRIDAE; ADMINISTRATION, CUTANEOUS; ANGIOPLASTY, BALLOON; ANIMALS; CELL DEATH; CORONARY ANGIOGRAPHY; ENDOTHELIUM, VASCULAR; GENE TRANSFER TECHNIQUES; ILIAC ARTERY; IN SITU NICK-END LABELING; MALE; RABBITS; TIME FACTORS;

ADENOVIRIDAE; ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0033586265     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018472     Document Type: Article

References (37)

1. ASADA, Y., KISANUKI, A., TSUNEYOSHI, A., MARUTSUKA, K., HATAKEYAMA, K., and SUMIYOSHI, A. (1996). Effects of inflation pressure of balloon catheter on vascular injuries and subsequent development of intimai hyperplasia in rabbit aorta. Atherosclerosis 121, 45-53.
2. BAEK, S., and MARCH, K.L. (1998). Gene therapy for restenosis: Getting nearer the heart of the matter. Circ. Res. 82, 295-305.
3. CHANG, M.W., BARR, E., LU, M.M., BARTON, K., and LEIDEN, J.M. (1995a). Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J. Clin. Invest. 96, 2260-2268.
4. CHANG, M.W., BARR., E., SELTZER, I., JIANG, Y., NABEL, G.J., NABEL, E.G., PARMACEK, M.S., and LEIDEN, J.M. (1995b). Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 267, 518-522.
5. CHEN, D., KRASINSKI, K., CHEN, D., SYLVESTER, A., CHEN, J., NISEN, P.D., and ANDRÉS, V. (1997). Down-regulation of cyclin-dependent kinase activity and cyclin A promoter activity in vascular smooth muscle cells by p27 (KIP-1), an inhibitor of neointima formation in the rat carotid artery. J. Clin. Invest. 99, 2334-2341.
6. CLESHAM, G.J., BROWNE, H., EFSTATHIOU, S., and WEISSBERG, P.L. (1996). Enhancer stimulation unmasks latent gene transfer after adenovirus-mediated gene delivery into human vascular smooth muscle cells. Circ. Res. 79, 1188-1195.
7. CLOWES, A.W., and SCHWARTZ, S.M. (1985). Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ. Res. 56, 139-145.
8. CLOWES, A.W., REIDY, M.A., and CLOWES, M.M. (1983). Kinetics of cellular proliferation after arterial injury. I. Smooth muscle cell growth in the absence of endothelium. Lab. Invest. 49, 327-333.
9. COUFFINHAL, T., KEARNEY, M., SULLIVAN, A., SILVER, M., TSURUMI, Y., and ISNER, J.M. (1997). Histochemical staining following LacZ gene transfer underestimates transfection efficiency. Hum. Gene Ther. 8, 929-934.
10. DOORNEKAMP, F.N.G., BORST, C., and POST, M.J. (1996). Endothelial cell recoverage and intimai hyperplasia after endothelium removal with or without smooth muscle cell necrosis in the rabbit carotid artery. J. Vasc. Res. 33, 146-155.
11. EPSTEIN, S.E., SPEIR, E., UNGER, E.F., GUZMAN, R.J., and FINKEL, T. (1994). The basis of molecular strategies for treating coronary restenosis after angioplasty. J. Am. Coll. Cardiol. 23, 1278-1288.
12. FELDMAN, L.J., STEG, P.G., ZHENG, L.P., CHEN, D., KEARNEY, M., MCGARR, S.E., BARRY, J.J., DEDIEU, J.F., PERRICAUDET, M., and ISNER, J.M. (1995). Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit. J. Clin. Invest. 95, 2662-2671.
13. FRENCH, B.A., et al. (1994). Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis. Circulation 90, 2402-2413.
14. GEARY, R.L., WILLIAMS, J.K., GOLDEN, D., BROWN, D.G., BENJAMIN, M.E., and ADAMS, M.R. (1996). Time course of cellular proliferation, intimal hyperplasia, and remodeling following angioplasty in monkeys with established atherosclerosis. A nonhuman primate model of restenosis. Arterioscler. Thromb. Vasc. Biol. 16, 34-43.
15. GUZMAN, R.J., LEMARCHAND, P., CRYSTAL, R.G., EPSTEIN, S.E., and FINKEL, T. (1993). Efficient and selective adenovirus-mediated gene transfer into vascular neointima. Circulation 88, 2838-2848.
16. GUZMAN, R.J., HIRSCHOWITZ, E.A., BRODY, S.L., CRYSTAL, R.G., EPSTEIN, S.E., and FINKEL, T. (1994). In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. U.S.A. 91, 10732-10736.
17. HANKE, H., STROHSCHNEIDER, T., OBEROFF, M., BETZ, E., and KARSCH, K.R. (1990). Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ. Res. 67, 651-659.
18. HARRELL, R.L., RAJANAYAGAM, S., DOANES, A.M., GUZMAN, R.J., HIRSCHOWITZ, E.A., CRYSTAL, R.G., EPSTEIN, S.E., and FINKEL, T. (1997). Inhibition of vascular smooth muscle cell proliferation and neointimal accumulation by adenovirus-mediated gene transfer of cytosine deaminase. Circulation 96, 621-627.
19. INDOLFI, C, ESPOSITO, G., DILORENZO, E., RAPACCIUOLO, A., FELICIELLO, A., PORCELLINI, A., AVVEDIMENTO, V.E., CONDORELLI, M., and CHIARIELLO, M. (1995). Smooth muscle cell proliferation is proportional to the degree of balloon injury in a rat model of angioplasty. Circulation 92, 1230-1235.
20. JAMAL, A., BENDECK, M., and LANGILLE, B.L. (1992). Structural changes and recovery of function after arterial injury. Arterioscl. Thromb. 12, 307-317.
21. MAILLARD, L., VAN BELLE, E., SMITH, R.C., LE ROUX, A., DENÈFLE, P., STEG, G., BARRY, J.J., BRANELLEC, D., ISNER, J.M., and WALSH, K. (1997). Percutaneous delivery of the gax gene inhibits vessel stenosis in a rabbit model of balloon angioplasty. Cardiovasc. Res. 35, 536-546.
22. MALIK, N., FRANCIS, S.E., HOLT, C.M., GUNN, J., THOMAS, G.L., SHEPHERD, L., CHAMBERLAIN, J., NEWMAN, C.M.H., CUMBERLAND, D.C., and CROSSMAN, D.C. (1998). Apoptosis and cell proliferation after porcine coronary angioplasty. Circulation 98, 1657-1665.
23. MARCH, K.L., MTTTEREDER, N., and TRAPNELL, B.C. (1993). Pharmacokinetics of adenoviral-mediated gene delivery to vascular smooth muscle cells: Implications for cardiovascular gene therapy. Circulation 88, 1-80. [Abstract]
24. MARCH, K.L., MADISON, I.E., and TRAPNELL, B.C. (1995). Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: Modulation by poloxamer 407 and implications for cardiovascular gene therapy. Hum. Gene Ther. 6, 41-53.
25. MULLER, D.W.M., ELLIS, S.G., and TOPOL, E.J. (1992). Experimental models of coronary artery restenosis. J. Am. Coll. Cardiol. 19,418-432.
26. OHNO, T., GORDON, D., SAN, H., POMPILI, V.J., IMPERIALE, M.J., NABEL, G.J., and NABEL, E.G. (1994). Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 265, 781-784.
27. OSWALD, H., HEINEMANN, F., NIKOL, S., SALMONS, B., and GUNZBURG, W.H. (1997). Removal of an inhibitor of marker enzyme activity in artery extracts by chelating agents. BioTechniques 21, 78-81.
28. PERLMAN, H., MAILLARD, L., KRASINSKI, K., and WALSH, K. (1997). Evidence for the rapid onset of apoptosis in medial smooth muscle cells following balloon injury. Circulation 95, 981-987.
29. REISSEN, R., and ISNER, J.M. (1994). Prospects for site-specific delivery of pharmacologic and molecular therapies. J. Am. Coll. Cardiol. 23, 1234-1244.
30. SATA, M., PERLMAN, H., MURUVE, D.A., SILVER, M., IKEBE, M., LIBERMANN, T.A., OETTGEN, P., and WALSH, K. (1998). Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. Proc. Natl. Acad. Sci. U.S.A. 95, 1213-1217.
31. SIMARI, R.D., SAN, H., REKHTER, M., OHNO, T., GORDON, D., NABEL, J., and NABEL, E.G. (1996). Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries. J. Clin. Invest. 98, 225-235.
32. CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev. 11, 1674-1689.
33. SMITH, R.C., WILLS, K.N., ANTELMAN, D., PERLMAN, H., TRUONG, L.N., KRASINSKI, K., and WALSH, K. (1997b). Adenoviral constructs encoding phosphorylation-competent full-length and truncated forms of the human retinoblastoma protein inhibit myocyte proliferation and neointima formation. Circulation 96, 1899-1905.
34. STADIUS, M.L., ROWAN, R., FLEISCHHAUER, J.F., KERNOFF, R., BILLINGHAM, M., and GOWN, A.M. (1992). Time course and cellular characteristics of the iliac artery response to acute balloon injury. An angiographic, morphometric, and immunocytochemical analysis in the cholesterol-fed New Zealand White rabbit. Arterioscl. Thromb. 12, 1267-1273.
35. STEG, P.G., TAHLIL, O., AUBAILLY, N., CAILLAUD, J.-M., DEDIEU, J.F., BERTHELOT, K., LE ROUX, A., FELDMAN, L., PERRICAUDET, M., DENÈFLE, P., and BRANELLEC, D. (1997). Reduction of restenosis after angioplasty in an atheromatous rabbit model by suicide gene therapy. Circulation 96, 408-411.
36. VAN BELLE, E., MAILLARD, L., RIVARD, A., FABRE, J.-E., COUFFINHAL, T., KEARNEY, M., BRANELLEC, D., FELDMAN, L.J., WALSH, K., and ISNER, J.M. (1988). Effects of Poloxamer 407 on transfection time and percutaneous adenovirus-mediated gene transfer in native and stented vessels. Hum. Gene Ther. 9, 1013-1024.
37. WEI, G.L., KRASINSKI, K., KEARNEY, M., ISNER, J.M., WALSH, K., and ANDRES, V. (1997). Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty. Circ. Res. 80, 418-426.